Anzeige
❌
Mehr »
Mittwoch, 18.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
NM

WKN: A2QEQY | ISIN: SE0014829255 | Ticker:
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEOLA MEDICAL AB Chart 1 Jahr
5-Tage-Chart
NEOLA MEDICAL AB 5-Tage-Chart

Aktuelle News zur NEOLA MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08:26Neola Medical AB Q3 Sales Increase4
08:00Neola Medical AB: Neola Medical Q3 Report 2026 - FDA Breakthrough Device Designation strengthens U.S. regulatory pathway42During the third quarter, Neola Medical reached a major regulatory milestone as the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to Neola®. The designation recognizes...
► Artikel lesen
04.09.Neola Medical AB: Neola Medical Receives FDA Breakthrough Device Designation 310Neola Medical AB (publ) today announces that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for Neola®, the Company's medical device for non-invasive, continuous...
► Artikel lesen
31.08.Neola Medical AB: Neola Medical Granted U.S. Design Patent Strengthening Protection of Neola User Interface297Neola Medical AB (publ) today announces that the United States Patent and Trademark Office (USPTO) has granted the company a design patent covering the graphical user interface of Neola®. The patent...
► Artikel lesen
20.08.Neola Medical weitet Verlust in Q2 2026 aus - Aktie gibt nach5
20.08.Neola Medical AB Q2 Loss Widens2
20.08.Neola Medical AB: Neola Medical Q2 Report 2026 - Clinical progress, secured financing and sharpened focus224During the quarter, Neola Medical reported positive safety results from its first clinical pilot study in preterm born babies in Sweden. The study confirmed a favorable safety profile of Neola® and...
► Artikel lesen
10.06.Neola Medical AB: Neola Medical granted Patent in the U.S. for reducing optical noise in lung monitoring measurements209Neola Medical AB (publ) has been granted a patent in the U.S. for a technical solution that reduces noise in measurements for continuous lung monitoring. The patent protects an innovation designed to...
► Artikel lesen
NEOLA MEDICAL Aktie jetzt für 0€ handeln
02.06.Listing of subscription rights and paid subscription shares of Neola Medical AB356With effect from June 03, 2026, the subscription rights in Neola Medical AB will be traded on First North Growth Market. Trading will continue up until and including June 12, 2026. ...
► Artikel lesen
19.05.Neola Medical AB: Neola Medical Q1 Report 2026 - Positive safety results from clinical study in preterm born babies strengthen the path toward market250During the quarter, Neola Medical completed enrollment and reported positive safety results from its first clinical pilot study in preterm born babies in Sweden. The study confirmed a favorable safety...
► Artikel lesen
21.04.Neola Medical AB: Neola Medical Reports Positive Safety Results from First Clinical Pilot Study and Advances Towards Next Phase of Clinical Development229Neola Medical today announces final results from its clinical pilot study, confirming a favorable safety profile of Neola® across the studied patient population, including very low birth weight preterm...
► Artikel lesen
16.03.Neola Medical AB: Neola Medical Completes Enrollment in Swedish Clinical Pilot Study500Neola Medical announces completion of patient enrollment in its clinical pilot study on preterm born babies in Sweden. All ten babies have now been included in the study, marking an important milestone...
► Artikel lesen
12.02.Neola Medical AB: Neola Medical Q4 Report 2025 - Advancing IP Protection as a Core Strategic Asset across Key Markets230During the quarter four new patents were granted, adding in total of seven new patent grants during 2025. This marks Neola Medical's strongest year to date in terms of IP protection across all key target...
► Artikel lesen
02.12.25Neola Medical AB: Neola Medical granted U.S. patent for disposable probes, strengthening future revenue model in target market259Neola Medical AB (publ) announces today that the company has been granted a U.S. patent protecting its disposable probes for the medical device Neola®. The advanced light and detector probes are used...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1